HEADER OXIDOREDUCTASE 15-FEB-13 3ZNO TITLE IN VITRO AND IN VIVO INHIBITION OF HUMAN D-AMINO ACID OXIDASE: TITLE 2 REGULATION OF D-SERINE CONCENTRATION IN THE BRAIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: D-AMINO-ACID OXIDASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: DAAO, DAMOX, DAO; COMPND 5 EC: 1.4.3.3; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) KEYWDS OXIDOREDUCTASE, NEUROTRANSMISSION EXPDTA X-RAY DIFFRACTION AUTHOR S.C.HOPKINS,M.L.R.HEFFERNAN,L.D.SARASWAT,C.A.BOWEN,L.MELNICK, AUTHOR 2 L.W.HARDY,M.A.ORSINI,M.S.ALLEN,P.KOCH,K.L.SPEAR,R.J.FOGLESONG, AUTHOR 3 M.SOUKRI,M.CHYTIL,Q.K.FANG,S.W.JONES,M.A.VARNEY,A.PANATIER, AUTHOR 4 S.H.R.OLIET,L.POLLEGIONI,L.PIUBELLI,G.MOLLA,M.NARDINI,T.H.LARGE REVDAT 3 20-DEC-23 3ZNO 1 REMARK REVDAT 2 22-MAY-13 3ZNO 1 JRNL REVDAT 1 15-MAY-13 3ZNO 0 JRNL AUTH S.C.HOPKINS,M.L.R.HEFFERNAN,L.D.SARASWAT,C.A.BOWEN, JRNL AUTH 2 L.MELNICK,L.W.HARDY,M.A.ORSINI,M.S.ALLEN,P.KOCH,K.L.SPEAR, JRNL AUTH 3 R.J.FOGLESONG,M.SOUKRI,M.CHYTIL,Q.K.FANG,S.W.JONES, JRNL AUTH 4 M.A.VARNEY,A.PANATIER,S.H.R.OLIET,L.POLLEGIONI,L.PIUBELLI, JRNL AUTH 5 G.MOLLA,M.NARDINI,T.H.LARGE JRNL TITL STRUCTURAL, KINETIC, AND PHARMACODYNAMIC MECHANISMS OF JRNL TITL 2 D-AMINO ACID OXIDASE INHIBITION BY SMALL MOLECULES. JRNL REF J.MED.CHEM. V. 56 3710 2013 JRNL REFN ISSN 0022-2623 JRNL PMID 23631755 JRNL DOI 10.1021/JM4002583 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.1 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.25 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 90.6 REMARK 3 NUMBER OF REFLECTIONS : 29206 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.221 REMARK 3 R VALUE (WORKING SET) : 0.217 REMARK 3 FREE R VALUE : 0.289 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.040 REMARK 3 FREE R VALUE TEST SET COUNT : 1471 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 15 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.38 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 90.58 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2907 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2238 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2748 REMARK 3 BIN R VALUE (WORKING SET) : 0.2184 REMARK 3 BIN FREE R VALUE : 0.3215 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.47 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 159 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5466 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 146 REMARK 3 SOLVENT ATOMS : 235 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 47.06 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 51.43 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.17150 REMARK 3 B22 (A**2) : 10.96070 REMARK 3 B33 (A**2) : -8.78910 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.332 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.606 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.311 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.536 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.309 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.920 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.863 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 5861 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 8006 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1959 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 175 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 863 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 5861 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 728 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 6678 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.16 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.80 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 21.85 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|1 - A|360 } REMARK 3 ORIGIN FOR THE GROUP (A): 1.9132 -21.3527 -55.6000 REMARK 3 T TENSOR REMARK 3 T11: -0.1419 T22: -0.0817 REMARK 3 T33: -0.0480 T12: -0.0046 REMARK 3 T13: -0.0337 T23: -0.0248 REMARK 3 L TENSOR REMARK 3 L11: 0.9841 L22: 0.8113 REMARK 3 L33: 1.8840 L12: -0.0644 REMARK 3 L13: 0.2572 L23: -0.0084 REMARK 3 S TENSOR REMARK 3 S11: 0.0538 S12: 0.0136 S13: -0.0392 REMARK 3 S21: 0.0233 S22: -0.0066 S23: 0.0056 REMARK 3 S31: 0.0649 S32: 0.0429 S33: -0.0473 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|1 - B|360 } REMARK 3 ORIGIN FOR THE GROUP (A): 1.3599 -3.0747 -15.7078 REMARK 3 T TENSOR REMARK 3 T11: -0.0983 T22: -0.0049 REMARK 3 T33: -0.1610 T12: 0.0143 REMARK 3 T13: -0.0791 T23: -0.1528 REMARK 3 L TENSOR REMARK 3 L11: 1.0880 L22: 2.0126 REMARK 3 L33: 1.2583 L12: -0.6834 REMARK 3 L13: -0.6419 L23: 1.0527 REMARK 3 S TENSOR REMARK 3 S11: -0.0578 S12: -0.3762 S13: 0.3073 REMARK 3 S21: 0.3244 S22: 0.1599 S23: -0.2796 REMARK 3 S31: 0.0699 S32: 0.1359 S33: -0.1021 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: RESIDUES A296-A303, A338-A340 B303, REMARK 3 B338-B340 ARE DISORDERED. POOR DENSITY IS PRESENT FOR RESIDUES REMARK 3 A296, A297, A298, A299, A300, A301, A302, A303, A338, A339, A340, REMARK 3 B55,B56, B57, B58, B59, B60, B61, B162, B163, B296, B297, B298, REMARK 3 B299, B300, B301, B302, B303, B338, B339, B340 FINAL STRUCTURE REMARK 3 HAS NO RESIDUES IN THE DISALLOWED REGION OF THE RAMACHANDRAN REMARK 3 PLOT AS DEFINED IN THE CCP4 PROCHECK PROGRAM. REMARK 4 REMARK 4 3ZNO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 15-FEB-13. REMARK 100 THE DEPOSITION ID IS D_1290055840. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN REMARK 200 INTENSITY-INTEGRATION SOFTWARE : D*TREK REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29214 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 64.930 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.6 REMARK 200 DATA REDUNDANCY : 4.210 REMARK 200 R MERGE (I) : 0.11000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.1 REMARK 200 DATA REDUNDANCY IN SHELL : 2.87 REMARK 200 R MERGE FOR SHELL (I) : 0.40000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 2DU8 REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.30 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.21 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 22.01550 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 129.86150 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 30.52800 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 129.86150 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 22.01550 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 30.52800 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6540 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 27300 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -31.1 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ARG A 341 REMARK 465 MET A 342 REMARK 465 PRO A 343 REMARK 465 PRO A 344 REMARK 465 SER A 345 REMARK 465 HIS A 346 REMARK 465 LEU A 347 REMARK 465 ARG B 341 REMARK 465 MET B 342 REMARK 465 PRO B 343 REMARK 465 PRO B 344 REMARK 465 SER B 345 REMARK 465 HIS B 346 REMARK 465 LEU B 347 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 29 51.10 -96.08 REMARK 500 PHE A 39 -163.08 -116.10 REMARK 500 THR A 40 -63.66 -11.50 REMARK 500 GLN A 53 111.37 -163.18 REMARK 500 PRO A 82 10.54 -62.23 REMARK 500 SER A 136 -157.64 -129.74 REMARK 500 ASP A 192 86.73 -152.90 REMARK 500 THR A 298 112.46 -36.57 REMARK 500 ASN A 308 78.14 -159.31 REMARK 500 LYS A 338 71.83 60.49 REMARK 500 LEU A 339 25.31 -145.56 REMARK 500 PRO B 29 97.31 -65.66 REMARK 500 THR B 40 -49.05 -18.97 REMARK 500 GLN B 53 109.66 -167.22 REMARK 500 SER B 136 -150.59 -120.48 REMARK 500 ASN B 225 40.13 -109.84 REMARK 500 ARG B 297 82.22 -69.66 REMARK 500 LEU B 339 -18.53 -144.33 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 583 DISTANCE = 7.14 ANGSTROMS REMARK 525 HOH A 606 DISTANCE = 7.02 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FAD A 350 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SE5 A 360 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FAD B 350 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SE5 B 360 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1341 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3ZNN RELATED DB: PDB REMARK 900 IN VITRO AND IN VIVO INHIBITION OF HUMAN D-AMINO ACID OXIDASE: REMARK 900 REGULATION OF D-SERINE CONCENTRATION IN THE BRAIN REMARK 900 RELATED ID: 3ZNP RELATED DB: PDB REMARK 900 IN VITRO AND IN VIVO INHIBITION OF HUMAN D-AMINO ACID OXIDASE: REMARK 900 REGULATION OF D-SERINE CONCENTRATION IN THE BRAIN REMARK 900 RELATED ID: 3ZNQ RELATED DB: PDB REMARK 900 IN VITRO AND IN VIVO INHIBITION OF HUMAN D-AMINO ACID OXIDASE: REMARK 900 REGULATION OF D-SERINE CONCENTRATION IN THE BRAIN DBREF 3ZNO A 1 347 UNP P14920 OXDA_HUMAN 1 347 DBREF 3ZNO B 1 347 UNP P14920 OXDA_HUMAN 1 347 SEQRES 1 A 347 MET ARG VAL VAL VAL ILE GLY ALA GLY VAL ILE GLY LEU SEQRES 2 A 347 SER THR ALA LEU CYS ILE HIS GLU ARG TYR HIS SER VAL SEQRES 3 A 347 LEU GLN PRO LEU ASP ILE LYS VAL TYR ALA ASP ARG PHE SEQRES 4 A 347 THR PRO LEU THR THR THR ASP VAL ALA ALA GLY LEU TRP SEQRES 5 A 347 GLN PRO TYR LEU SER ASP PRO ASN ASN PRO GLN GLU ALA SEQRES 6 A 347 ASP TRP SER GLN GLN THR PHE ASP TYR LEU LEU SER HIS SEQRES 7 A 347 VAL HIS SER PRO ASN ALA GLU ASN LEU GLY LEU PHE LEU SEQRES 8 A 347 ILE SER GLY TYR ASN LEU PHE HIS GLU ALA ILE PRO ASP SEQRES 9 A 347 PRO SER TRP LYS ASP THR VAL LEU GLY PHE ARG LYS LEU SEQRES 10 A 347 THR PRO ARG GLU LEU ASP MET PHE PRO ASP TYR GLY TYR SEQRES 11 A 347 GLY TRP PHE HIS THR SER LEU ILE LEU GLU GLY LYS ASN SEQRES 12 A 347 TYR LEU GLN TRP LEU THR GLU ARG LEU THR GLU ARG GLY SEQRES 13 A 347 VAL LYS PHE PHE GLN ARG LYS VAL GLU SER PHE GLU GLU SEQRES 14 A 347 VAL ALA ARG GLU GLY ALA ASP VAL ILE VAL ASN CYS THR SEQRES 15 A 347 GLY VAL TRP ALA GLY ALA LEU GLN ARG ASP PRO LEU LEU SEQRES 16 A 347 GLN PRO GLY ARG GLY GLN ILE MET LYS VAL ASP ALA PRO SEQRES 17 A 347 TRP MET LYS HIS PHE ILE LEU THR HIS ASP PRO GLU ARG SEQRES 18 A 347 GLY ILE TYR ASN SER PRO TYR ILE ILE PRO GLY THR GLN SEQRES 19 A 347 THR VAL THR LEU GLY GLY ILE PHE GLN LEU GLY ASN TRP SEQRES 20 A 347 SER GLU LEU ASN ASN ILE GLN ASP HIS ASN THR ILE TRP SEQRES 21 A 347 GLU GLY CYS CYS ARG LEU GLU PRO THR LEU LYS ASN ALA SEQRES 22 A 347 ARG ILE ILE GLY GLU ARG THR GLY PHE ARG PRO VAL ARG SEQRES 23 A 347 PRO GLN ILE ARG LEU GLU ARG GLU GLN LEU ARG THR GLY SEQRES 24 A 347 PRO SER ASN THR GLU VAL ILE HIS ASN TYR GLY HIS GLY SEQRES 25 A 347 GLY TYR GLY LEU THR ILE HIS TRP GLY CYS ALA LEU GLU SEQRES 26 A 347 ALA ALA LYS LEU PHE GLY ARG ILE LEU GLU GLU LYS LYS SEQRES 27 A 347 LEU SER ARG MET PRO PRO SER HIS LEU SEQRES 1 B 347 MET ARG VAL VAL VAL ILE GLY ALA GLY VAL ILE GLY LEU SEQRES 2 B 347 SER THR ALA LEU CYS ILE HIS GLU ARG TYR HIS SER VAL SEQRES 3 B 347 LEU GLN PRO LEU ASP ILE LYS VAL TYR ALA ASP ARG PHE SEQRES 4 B 347 THR PRO LEU THR THR THR ASP VAL ALA ALA GLY LEU TRP SEQRES 5 B 347 GLN PRO TYR LEU SER ASP PRO ASN ASN PRO GLN GLU ALA SEQRES 6 B 347 ASP TRP SER GLN GLN THR PHE ASP TYR LEU LEU SER HIS SEQRES 7 B 347 VAL HIS SER PRO ASN ALA GLU ASN LEU GLY LEU PHE LEU SEQRES 8 B 347 ILE SER GLY TYR ASN LEU PHE HIS GLU ALA ILE PRO ASP SEQRES 9 B 347 PRO SER TRP LYS ASP THR VAL LEU GLY PHE ARG LYS LEU SEQRES 10 B 347 THR PRO ARG GLU LEU ASP MET PHE PRO ASP TYR GLY TYR SEQRES 11 B 347 GLY TRP PHE HIS THR SER LEU ILE LEU GLU GLY LYS ASN SEQRES 12 B 347 TYR LEU GLN TRP LEU THR GLU ARG LEU THR GLU ARG GLY SEQRES 13 B 347 VAL LYS PHE PHE GLN ARG LYS VAL GLU SER PHE GLU GLU SEQRES 14 B 347 VAL ALA ARG GLU GLY ALA ASP VAL ILE VAL ASN CYS THR SEQRES 15 B 347 GLY VAL TRP ALA GLY ALA LEU GLN ARG ASP PRO LEU LEU SEQRES 16 B 347 GLN PRO GLY ARG GLY GLN ILE MET LYS VAL ASP ALA PRO SEQRES 17 B 347 TRP MET LYS HIS PHE ILE LEU THR HIS ASP PRO GLU ARG SEQRES 18 B 347 GLY ILE TYR ASN SER PRO TYR ILE ILE PRO GLY THR GLN SEQRES 19 B 347 THR VAL THR LEU GLY GLY ILE PHE GLN LEU GLY ASN TRP SEQRES 20 B 347 SER GLU LEU ASN ASN ILE GLN ASP HIS ASN THR ILE TRP SEQRES 21 B 347 GLU GLY CYS CYS ARG LEU GLU PRO THR LEU LYS ASN ALA SEQRES 22 B 347 ARG ILE ILE GLY GLU ARG THR GLY PHE ARG PRO VAL ARG SEQRES 23 B 347 PRO GLN ILE ARG LEU GLU ARG GLU GLN LEU ARG THR GLY SEQRES 24 B 347 PRO SER ASN THR GLU VAL ILE HIS ASN TYR GLY HIS GLY SEQRES 25 B 347 GLY TYR GLY LEU THR ILE HIS TRP GLY CYS ALA LEU GLU SEQRES 26 B 347 ALA ALA LYS LEU PHE GLY ARG ILE LEU GLU GLU LYS LYS SEQRES 27 B 347 LEU SER ARG MET PRO PRO SER HIS LEU HET FAD A 350 53 HET SE5 A 360 17 HET GOL A1341 6 HET FAD B 350 53 HET SE5 B 360 17 HETNAM FAD FLAVIN-ADENINE DINUCLEOTIDE HETNAM SE5 4-(4-CHLOROPHENETHYL)-1H-PYRROLE-2-CARBOXYLIC ACID HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 FAD 2(C27 H33 N9 O15 P2) FORMUL 4 SE5 2(C13 H12 CL N O2) FORMUL 5 GOL C3 H8 O3 FORMUL 8 HOH *235(H2 O) HELIX 1 1 GLY A 9 HIS A 24 1 16 HELIX 2 2 THR A 44 ALA A 48 5 5 HELIX 3 3 ASN A 61 VAL A 79 1 19 HELIX 4 4 ASN A 83 GLY A 88 1 6 HELIX 5 5 THR A 118 ASP A 123 1 6 HELIX 6 6 GLU A 140 ARG A 155 1 16 HELIX 7 7 SER A 166 GLU A 173 1 8 HELIX 8 8 THR A 182 LEU A 189 5 8 HELIX 9 9 ASN A 252 GLU A 267 1 16 HELIX 10 10 PRO A 268 ALA A 273 5 6 HELIX 11 11 TYR A 314 LYS A 338 1 25 HELIX 12 12 GLY B 9 HIS B 24 1 16 HELIX 13 13 THR B 43 ALA B 48 1 6 HELIX 14 14 PRO B 62 HIS B 78 1 17 HELIX 15 15 ASN B 83 GLY B 88 1 6 HELIX 16 16 PRO B 105 THR B 110 5 6 HELIX 17 17 THR B 118 ASP B 123 1 6 HELIX 18 18 GLU B 140 GLU B 154 1 15 HELIX 19 19 SER B 166 GLU B 173 1 8 HELIX 20 20 THR B 182 LEU B 189 5 8 HELIX 21 21 ASN B 252 GLU B 267 1 16 HELIX 22 22 PRO B 268 ALA B 273 5 6 HELIX 23 23 HIS B 311 GLY B 313 5 3 HELIX 24 24 TYR B 314 LYS B 337 1 24 SHEET 1 AA 6 LYS A 158 GLN A 161 0 SHEET 2 AA 6 ASP A 31 ALA A 36 1 O ILE A 32 N LYS A 158 SHEET 3 AA 6 ARG A 2 ILE A 6 1 O VAL A 3 N LYS A 33 SHEET 4 AA 6 VAL A 177 ASN A 180 1 O VAL A 177 N VAL A 4 SHEET 5 AA 6 THR A 303 TYR A 309 1 O GLU A 304 N ILE A 178 SHEET 6 AA 6 ARG A 290 LEU A 296 -1 O ARG A 290 N TYR A 309 SHEET 1 AB 8 LEU A 112 LYS A 116 0 SHEET 2 AB 8 TYR A 130 LEU A 139 -1 O PHE A 133 N ARG A 115 SHEET 3 AB 8 LEU A 89 PHE A 98 -1 O PHE A 90 N ILE A 138 SHEET 4 AB 8 PHE A 213 HIS A 217 1 O PHE A 213 N TYR A 95 SHEET 5 AB 8 TYR A 228 PRO A 231 -1 O ILE A 229 N ILE A 214 SHEET 6 AB 8 VAL A 236 GLY A 239 -1 O THR A 237 N ILE A 230 SHEET 7 AB 8 GLN A 196 ASP A 206 -1 O MET A 203 N LEU A 238 SHEET 8 AB 8 GLN A 243 LEU A 244 1 O GLN A 243 N ARG A 199 SHEET 1 AC 8 LEU A 112 LYS A 116 0 SHEET 2 AC 8 TYR A 130 LEU A 139 -1 O PHE A 133 N ARG A 115 SHEET 3 AC 8 LEU A 89 PHE A 98 -1 O PHE A 90 N ILE A 138 SHEET 4 AC 8 PHE A 213 HIS A 217 1 O PHE A 213 N TYR A 95 SHEET 5 AC 8 TYR A 228 PRO A 231 -1 O ILE A 229 N ILE A 214 SHEET 6 AC 8 VAL A 236 GLY A 239 -1 O THR A 237 N ILE A 230 SHEET 7 AC 8 GLN A 196 ASP A 206 -1 O MET A 203 N LEU A 238 SHEET 8 AC 8 ARG A 274 VAL A 285 -1 O ARG A 274 N ASP A 206 SHEET 1 AD 2 GLN A 243 LEU A 244 0 SHEET 2 AD 2 GLN A 196 ASP A 206 1 O ARG A 199 N GLN A 243 SHEET 1 BA 6 LYS B 158 GLN B 161 0 SHEET 2 BA 6 ASP B 31 ALA B 36 1 O ILE B 32 N LYS B 158 SHEET 3 BA 6 ARG B 2 ILE B 6 1 O VAL B 3 N LYS B 33 SHEET 4 BA 6 VAL B 177 ASN B 180 1 O VAL B 177 N VAL B 4 SHEET 5 BA 6 THR B 303 TYR B 309 1 O GLU B 304 N ILE B 178 SHEET 6 BA 6 ARG B 290 LEU B 296 -1 O ARG B 290 N TYR B 309 SHEET 1 BB 8 LEU B 112 LYS B 116 0 SHEET 2 BB 8 TYR B 130 LEU B 139 -1 O PHE B 133 N ARG B 115 SHEET 3 BB 8 LEU B 89 PHE B 98 -1 O PHE B 90 N ILE B 138 SHEET 4 BB 8 HIS B 212 THR B 216 1 O PHE B 213 N TYR B 95 SHEET 5 BB 8 TYR B 228 PRO B 231 -1 O ILE B 229 N ILE B 214 SHEET 6 BB 8 VAL B 236 GLY B 239 -1 O THR B 237 N ILE B 230 SHEET 7 BB 8 GLN B 196 ASP B 206 -1 O MET B 203 N LEU B 238 SHEET 8 BB 8 GLN B 243 LEU B 244 1 N GLN B 243 O ARG B 199 SHEET 1 BC 8 LEU B 112 LYS B 116 0 SHEET 2 BC 8 TYR B 130 LEU B 139 -1 O PHE B 133 N ARG B 115 SHEET 3 BC 8 LEU B 89 PHE B 98 -1 O PHE B 90 N ILE B 138 SHEET 4 BC 8 HIS B 212 THR B 216 1 O PHE B 213 N TYR B 95 SHEET 5 BC 8 TYR B 228 PRO B 231 -1 O ILE B 229 N ILE B 214 SHEET 6 BC 8 VAL B 236 GLY B 239 -1 O THR B 237 N ILE B 230 SHEET 7 BC 8 GLN B 196 ASP B 206 -1 O MET B 203 N LEU B 238 SHEET 8 BC 8 ARG B 274 VAL B 285 -1 O ARG B 274 N ASP B 206 SHEET 1 BD 2 GLN B 243 LEU B 244 0 SHEET 2 BD 2 GLN B 196 ASP B 206 1 O ARG B 199 N GLN B 243 CISPEP 1 PRO A 59 ASN A 60 0 -6.96 SITE 1 AC1 41 ILE A 6 GLY A 7 ALA A 8 GLY A 9 SITE 2 AC1 41 VAL A 10 ILE A 11 ALA A 36 ASP A 37 SITE 3 AC1 41 ARG A 38 THR A 43 THR A 44 THR A 45 SITE 4 AC1 41 VAL A 47 ALA A 48 ALA A 49 GLY A 50 SITE 5 AC1 41 LEU A 51 ARG A 162 LYS A 163 VAL A 164 SITE 6 AC1 41 CYS A 181 THR A 182 GLY A 183 TRP A 185 SITE 7 AC1 41 ILE A 202 TYR A 228 GLY A 281 ARG A 283 SITE 8 AC1 41 HIS A 311 GLY A 312 GLY A 313 TYR A 314 SITE 9 AC1 41 GLY A 315 LEU A 316 THR A 317 SE5 A 360 SITE 10 AC1 41 HOH A 537 HOH A 579 HOH A 581 HOH A 582 SITE 11 AC1 41 HOH A 601 SITE 1 AC2 9 LEU A 56 LEU A 215 ILE A 223 TYR A 224 SITE 2 AC2 9 TYR A 228 ILE A 230 ARG A 283 GLY A 313 SITE 3 AC2 9 FAD A 350 SITE 1 AC3 32 ILE B 6 GLY B 7 ALA B 8 GLY B 9 SITE 2 AC3 32 VAL B 10 ILE B 11 ALA B 36 ASP B 37 SITE 3 AC3 32 ARG B 38 THR B 44 THR B 45 ALA B 48 SITE 4 AC3 32 GLY B 50 LEU B 51 ARG B 162 VAL B 164 SITE 5 AC3 32 CYS B 181 THR B 182 GLY B 183 TRP B 185 SITE 6 AC3 32 ILE B 202 TYR B 228 ARG B 283 GLY B 312 SITE 7 AC3 32 GLY B 313 TYR B 314 GLY B 315 LEU B 316 SITE 8 AC3 32 THR B 317 SE5 B 360 HOH B 526 HOH B 591 SITE 1 AC4 7 HIS B 217 ILE B 223 TYR B 224 TYR B 228 SITE 2 AC4 7 ARG B 283 GLY B 313 FAD B 350 SITE 1 AC5 5 HIS A 212 GLU A 267 HOH A 567 HIS B 80 SITE 2 AC5 5 LEU B 91 CRYST1 44.031 61.056 259.723 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022711 0.000000 0.000000 0.00000 SCALE2 0.000000 0.016378 0.000000 0.00000 SCALE3 0.000000 0.000000 0.003850 0.00000